{"id":"W2131166024","doi":"10.1007/s003840100285","title":"Use of anti-tumour necrosis factor agents in inflammatory bowel disease","year":2001,"lang":"en","type":"article","venue":"International Journal of Colorectal Disease","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Ontario Tech University","funders":"United European Gastroenterology","keywords":"Infliximab; Medicine; Adalimumab; Intensive care medicine; Grading (engineering); Disease; Inflammatory bowel disease; Clinical trial; Certolizumab pegol; Hepatology; MEDLINE; Etanercept; Crohn's disease; Internal medicine; Tumor necrosis factor alpha; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004654479,0.0001962597,0.0006139278,0.0004989267,0.0003037853,0.0003786401,0.0001578468,0.0004718499,0.001207183],"category_scores_gemma":[0.001499725,0.00008720412,0.0004404091,0.0005170753,0.0001674692,0.0002302649,0.0001832381,0.000706816,0.0003149264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002971412,"about_ca_system_score_gemma":0.0002368041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003329526,"about_ca_topic_score_gemma":0.000575521,"domain_scores_codex":[0.9995758,0.0001644767,0.00005615544,0.00003791841,0.0001142673,0.00005145497],"domain_scores_gemma":[0.9991586,0.0003604123,0.0002649539,0.00003750405,0.00007205678,0.0001064755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01933721,0.002300302,0.1462462,0.001907563,0.0009716412,0.00477043,0.0002966461,0.0004818,0.0542341,0.001014452,0.002957294,0.7654824],"study_design_scores_gemma":[0.003661965,0.05155102,0.6136886,0.001586318,0.003416809,0.03821068,0.0007001245,0.001443602,0.06555696,0.001596434,0.2184912,0.00009633898],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6043015,0.3748697,0.001569176,0.003134505,0.001019258,0.00005327227,0.0002199521,0.00005146891,0.01478115],"genre_scores_gemma":[0.9271327,0.0673298,0.0009136535,0.0007694703,0.0009337391,0.00003947057,0.0001354428,0.000008485267,0.002737177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001207183,"threshold_uncertainty_score":0.004038393,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01724662855306872,"score_gpt":0.272653483049452,"score_spread":0.2554068544963833,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}